Navigation Links
Chantix Blamed for Suicide in Lawsuit Against Pfizer Filed by Cory Watson Crowder & DeGaris

BIRMINGHAM, Ala., July 9 /PRNewswire/ -- A lawsuit charges pharmaceutical giant Pfizer was motivated by greed when it failed to warn the public of potentially deadly side-effects associated with its popular smoking cessation drug varenicline which is marketed under the trade name Chantix. The suit, brought by the widow of an Indiana man, alleges the decedent committed suicide after using Chantix as prescribed. The victim's tragic death occurred only a few days before the information contained in the drug label and package insert for patients was amended to include warnings for the increased risk of experiencing suicide and similar tragedies. Further, the widow blames Pfizer in the lawsuit by identifying many specific instances of bad conduct, and suggests that Pfizer pursued profit over patient safety.

"This man's death was a direct result of taking the drug Chantix," said Kristian Rasmussen, veteran pharmaceutical litigation attorney with the law firm Cory Watson Crowder & DeGaris. Rasmussen and attorney William E. Winingham of Wilson, Kehoe and Winingham are representing the victim's widow.

The suit says the man was not warned of potentially devastating side effects when he began taking Chantix in October 2007. The man died of a self-inflicted gunshot wound in January, 2008. Less than a month after the Plaintiff committed suicide, Pfizer modified the package insert on Chantix to recommend that all patients being treated with Chantix "be observed for neuropsychiatric symptoms including ... suicidal ideation and suicidal behavior."

"Pfizer's action was too little too late," said Rasmussen. The lawsuit accuses Pfizer of putting profits before patient safety and claims Pfizer failed to report suspected side effects for fear the warnings would cut into sales and profits. Chantix revenues reached $883 million in 2007, according to corporate performance reports available on the company's website. The suit seeks unspecified damages and accuses Pfizer of intentionally, recklessly and or negligently concealing, suppressing, omitting or misrepresenting the risks, dangers, defects and disadvantages of Chantix.

About Cory Watson Crowder & DeGaris

Cory Watson Crowder & DeGaris is recognized nationally for its practice in mass torts litigation, multidistrict litigation and complex litigation including class actions, products liability, business and securities litigation, environmental litigation and mass torts litigation of defective medical devices and pharmaceuticals.

SOURCE Cory Watson Crowder & DeGaris
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Litigation Predicted in Wake of FAA Ban of Chantix Use by Pilots and Air Traffic Controllers: Smoking Cessation Drug Target of Controversy
2. Road pollution blamed for higher allergy risk in kids
3. People with anorexia less likely to be blamed when biology, genetics explained
4. Filtered Cigarettes Blamed for Huge Rise in Type of Lung Cancer
5. Antidepressants in suicide prevention
6. As I-1000 Signatures are Counted, Washington State Medical Association Opposition to Physician-Assisted Suicide Reiterated
7. Hope, Volume One, a CD benefiting Suicide Awareness Voices of Education (SAVE), to Be released on June 24, 2008
8. Drink and drugs fuel Scottish suicide and homicide rates
9. Growing Public Health Crisis of Domestic Violence and Suicides by Returning Veterans
10. Californians Against Assisted Suicide - Controversial Bill, AB 2747 Narrowly Passes Assembly
11. VA Secretary Appoints Panel of National Suicide Experts
Post Your Comments:
(Date:12/1/2015)... (PRWEB) , ... December 02, 2015 , ... ... research “ Gastrointestinal events and association with initiation of treatment for osteoporosis ”. ... the use of pharmacological treatment in patients diagnosed with osteoporosis. Based on a ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... its acquisition by Jordan Industries International, LLC (“JII”). , With support from JII, ... and maintenance services to hospitals, surgery centers, clinics, research labs and medical facilities ...
(Date:12/1/2015)... ... , ... According to an article published on November 16th by ... U.S. Department of Health and Human Services, claiming that any states which do not ... clause in the law prohibiting the denial of coverage for pre-existing conditions. The article ...
(Date:12/1/2015)... ... December 01, 2015 , ... Baptist Medical Center Jacksonville ... is the only hospital in the region providing what is known as the ... pacing patients were revealed recently at a medical conference and published in The ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Paul Vitenas, one of ... has been named by MedEsthetics magazine as the Best Single Physician Practice in the ... the many elite aesthetic physicians honored by the industry publication. , Dr. Vitenas ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 01, 2015 ... the "Medium Molecular Weight Polyisobutylene Market ... Other Applications - Global Industry Analysis, Size, ... 2023" report to their offering. ... addition of the "Medium Molecular Weight ...
(Date:12/1/2015)... CLEVELAND , Dec. 1, 2015   ... innovation firm, today announced the publication of a ... Entering the Direct-to-Consumer Medical Market". The whitepaper gives ... roadmap for successfully penetrating this lucrative segment. ... purchase healthcare products to manage their own health, ...
(Date:12/1/2015)... 1, 2015 Array BioPharma Inc. ... its Chief Executive Officer, Ron Squarer ... Healthcare Conference in New York.  The public ... through a webcast on the Array BioPharma ... --> , ...
Breaking Medicine Technology: